Risk of introducing Zika virus in the Canadian cord blood supply: A risk analysis
Transfusion · 2024
DOI: 10.1111/trf.18056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Antoine Lewin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs and Innovation, Héma-Québec, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Fetal Blood, Blood Donors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Héma-Québec.
Abstract (Originalsprache)
Background
In Canada, as many as 24% of mothers are deferred from cord blood (CB) donation due to risk factors for Zika virus (ZIKV). However, the ZIKV epidemic has waned considerably since 2016, and there has not been any report of ZIKV transmission by CB transplantation, which questions this policy. Thus, we performed an analysis of the risk of introducing ZIKV in the CB supply maintained by Héma‐Québec (HQ) and Canadian Blood Services (CBS). Study Design and Methods This simulation considered the following parameters: the risk of travel exposure in a high‐risk ZIKV country, the duration of travel, the daily risk of acquiring ZIKV in a high‐risk country, the probability of materno‐fetal ZIKV transmission, the probability of asymptomatic fetal viremia, and the probability of sexual transmission. A hundred million Monte Carlo simulations were run.
Results
In the most‐likely scenario (probability of traveling to a high‐risk ZIKV country while pregnant = 0.178), the risk was estimated at 0.9 ZIKV‐positive donations per million donations (95% confidence interval [CI] = 0.4–1.6)—or one every 868 years at HQ and one every 453 years at CBS. In the pessimistic model (probability of traveling to a high‐risk ZIKV country while pregnant = 0.240), the risk was estimated at 1.2 ZIKV‐positive donations per million donations (95% CI = 0.6–2.1)—or one every 644 years at HQ and one every 340 years at CBS.
Discussion
We conclude that the risk of introducing ZIKV in the Canadian CB supply is too small to justify maintaining the current policy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Affairs and Innovation, Héma-Québec, Montreal, Quebec, Canada.
- Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
- Stem Cells, Canadian Blood Services, Ottawa, Ontario, Canada.
- Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Transfusion Medicine, Héma-Québec, Montreal, Quebec, Canada.
ORCID-Profile: Antoine Lewin, Sheila F O'Brien, Matthew Seftel, Catherine Latour
Förderung
- Héma-Québec
Zitieren
APA
Lewin, A., O'Brien, S. F., Seftel, M., Latour, C., Allan, D., Chouinard, M. C., Fournier, D., & Renaud, C. (2024). Risk of introducing Zika virus in the Canadian cord blood supply: A risk analysis. Transfusion. https://doi.org/10.1111/trf.18056
Vancouver
Lewin A, O'Brien SF, Seftel M, Latour C, Allan D, Chouinard MC, et al. Risk of introducing Zika virus in the Canadian cord blood supply: A risk analysis. Transfusion. 2024. doi:10.1111/trf.18056
BibTeX
@article{Lewin2024,
author = {Lewin, Antoine and O'Brien, Sheila F and Seftel, Matthew and Latour, Catherine and Allan, David and Chouinard, Marie-Claude and Fournier, Diane and Renaud, Christian},
title = {Risk of introducing Zika virus in the Canadian cord blood supply: A risk analysis},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.18056}
}
EUVIMED